Federation des caisses Desjardins du Quebec
Position in NXL — Nexalin Technology, Inc.
CIK 2022297
LEVIS, A8
Position in NXL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$288
New position
Shares Held
29
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 20 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Medical Devices
Healthcare · as of Jun 30, 2026Federation des caisses Desjardins du Quebec holds $211,456,671 across 44 Medical Devices names. NXL ranks #38 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
743,709 | $67,484,151 | |
| 2 | MDT |
Medtronic plc
|
672,651 | $52,621,486 | |
| 3 | SYK |
Stryker Corp
|
130,577 | $41,110,860 | |
| 4 | BSX |
Boston Scientific Corp
|
286,032 | $12,207,843 | |
| 5 | EW |
Edwards Lifesciences Corp
|
127,697 | $11,551,468 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
144,566 | $9,253,667 | |
| 7 | GMED |
Globus Medical Inc
|
58,976 | $4,659,692 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
35,277 | $3,036,994 |
All Filings in NXL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $288 | 873 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||